Clinical trial · Observational
An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed
Non-small Cell Lung Cancer: The Impact of Ethnic Origin on Patients Being Treated Second Line With Pemetrexed - An Observational Study
NCT00497770CI-TRIAL-00006833completedResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This large, non-randomized observational study is being conducted to provide data about the impact of ethnic origin on outcomes and resource utilization during the 2nd line treatment of non-small cell lung cancer (NSCLC) in a routine medical care setting.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Neoplasms | Lung Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pemetrexed | Drug | Pemetrexed | ALIAS |
Design
Arms and outcomes
Arms (4)
- label
- Caucasian
- description
- Caucasian patients receiving Alimta for 2nd line NSCLC
- interventionNames
- Drug: Pemetrexed
- label
- African American
- description
- African American patients receiving Alimta for 2nd line NSCLC
- interventionNames
- Drug: Pemetrexed
- label
- Asian American
- description
- Asian American patients receiving Alimta for 2nd line NSCLC
- interventionNames
- Drug: Pemetrexed
- label
- Hispanic
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Non-small cell lung cancer (NSCLC) (any histologic type) * Stage IIIB or IV disease * Should have had 1 line of chemotherapy for Metastatic disease * Adequate hematologic, hepatic and renal function * Measurable or evaluable disease Exclusion Criteria: * Pregnant or lactating females
References
Publications (0)
Data not yet available
No reference posted for this study.